The CME/CE-accredited MDS Rounds Program provides a forum for health care professionals who care for patients with bone marrow failure disorders to address issues related to the diagnosis and treatment of patients with myelodysplastic syndromes (MDS). Participants will learn the latest information on new therapies and advances in the management of MDS through lecture and case studies developed and presented by an expert in hematology/oncology.
Designed for a standard one-hour program format, this program has been developed by the Aplastic Anemia and MDS International Foundation (AAMDSIF) and accredited by USF Health. It is available at no charge for medical centers to provide for their professional staff.
Need for Professional Education on MDS
The diagnosis and prognosis of myeloid malignancies are challenging for clinicians, particularly because myelodysplastic syndrome and related blood disorders are not common illnesses. The list of conditions that can imitate MDS is lengthy, and there is often a complex relationship between clinical symptoms and genetic mutation profiles.
• During the past decade, extensive research on the biology of bone marrow failure disorders has stimulated new insights into the disease pathophysiology. These have led to improved categorization of patients and risk stratification, and have enhanced assessment of therapeutic response at the subclinical level as well as produced new and innovative approaches to treatment. Community-based physicians who may see few of these patients need to better understand the areas of similarity and difference between MDS and other bone marrow failure diseases, so that a correct diagnosis can be made and the best treatment offered.
• The intricacies of these factors and their interactions tend to create knowledge and practice gaps among health care providers caring for this patient population. These gaps are especially predominant among those not working in academic centers or those years away from their academic studies. While community hematologists may not see as many patients as practitioners in academic medical centers, increased familiarity with current diagnosis and treatment regimens assists these clinicians in providing state of the art care to patients.
• A survey of MDS patients conducted by the Aplastic Anemia & MDS International Foundation in 2008 indicated a disconnect between what MDS patients are comprehending about their disease and what key information their physicians may be telling them. A subsequent survey conducted in 2013 also confirmed this gap in understanding, particularly regarding treatment decision-making based on quality of life issues. Case-based education programs which address the most current evidence and guidelines for clinical application enable practitioners to more effectively communicate the prognosis and treatment options available to patients.
This activity is intended for hematologists, oncologists, hospitalists, internists, primary care physicians, physician assistants, nurse practitioners, nurses, and other health care professionals.
Our accredited provider, USF Health, will be offering the following continuing education credits:
1.0 hour of AMA PRA Category 1 CreditTM
1.0 hour of ANCC Credit
For more information and scheduling please contact:
Director of Health Professional Programs
Aplastic Anemia and MDS International Foundation
4330 East West Highway, Suite 230, Bethesda, MD 20814
(301)279-7202, ext. 101